Biographica, a biotechnology firm in London, has garnered £7 million from various investors, spearheaded by Faber VC. The funding aims to advance their AI-based platform for developing new crop traits. Establishing partnerships with seed industry leaders, the firm intends to revolutionize how new, resilient crops are developed. The company‘s innovative approach promises to cut down crop development timelines significantly. Furthermore, Biographica’s potential to transform agricultural methods is anticipated to attract more attention from industry stakeholders.
How does AI identify genetic targets swiftly?
The agriculture industry often experiences lengthy timelines and high costs associated with developing new crop traits like drought resistance and nutrition improvements. Biographica seeks to alleviate these hurdles by employing AI-driven methodologies. Its platform innovatively identifies promising genetic targets within weeks, which traditionally takes much longer, aiding gene editing and breeding decisions. By implementing AI, Biographica shortens development timelines by up to five years and lowers research and development costs.
How effective is Biographica’s AI in practice?
Pilot projects with seed and precision breeding companies underscore the effectiveness of Biographica’s platform, showing it identifies validated gene targets as much as 12 times quicker than conventional methods. Additionally, it discovers novel targets overlooked by traditional approaches. The integration of AI and experimental validation via the “lab-in-the-loop” model further accelerates and enhances trait development.
A recent partnership with BASF | Nunhems illustrates Biographica’s influence in the agricultural sector. This collaboration aims to aid in the development of new crop varieties, strengthening their presence and capabilities in the industry. The firm’s successful fundraising will facilitate the expansion of their platform, enabling more partnerships and development of additional crop traits.
We’ve seen AI reshape pharma, turning trial-and-error pipelines into learnable biological systems — and it works. We’re bringing that same discipline to crops.
Cecily Price, CEO of Biographica, highlighted the transformative potential of AI in agriculture. As technology previously transformed pharmaceuticals by turning trial-and-error processes into learnable systems, similar advancements are expected with crop development.
On looking back, agricultural biotechnology companies have been continuously exploring ways to enhance crop traits. However, Biographica’s rapid identification of gene targets using AI marks a significant acceleration compared to past methodologies, which often proved time-intensive and costly.
As Biographica advances its cutting-edge platform, the agricultural industry may see more rapid, efficient crop development processes. This approach could prompt other biotech companies to adopt similar methodologies, potentially revolutionizing the landscape across the agriculture sector. By focusing on cost-effectiveness and faster timelines, such strategies can result in more sustainable agricultural practices in the long run.
